ODI Pharma AB
Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.
ODI | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0013409760 (+2 more)
- LEI:
- 8945001MNHCQFIP27M14
- Country:
- Sweden
- Address:
- Östermalmstorg 1, 114 42 Stockholm
- Website:
- https://www.odipharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ODI Pharma AB is a pharmaceutical company established in 2018, specializing in medicinal cannabis with the goal of improving patients' lives. The company acts as a producer and representative of finished pharmaceutical cannabis products, with a strategic focus on distribution. It operates through a European network of subsidiaries and partners, supplying a range of products including dried flowers with varying THC and CBD levels. A cornerstone of its business is an exclusive partnership with Synoptis Pharma, part of the NEUCA Group, to distribute its products across numerous countries in Eastern Europe, with a notable focus on the Polish market. The company operates under strict governmental supervision and regulation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ODI Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ODI Pharma AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ODI Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
